Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer
Primary Purpose
Lymphedema of Limb, Sentinel Lymph Node
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Early lymphedema detection
Usual follow-up
Sponsored by
About this trial
This is an interventional diagnostic trial for Lymphedema of Limb focused on measuring physiotherapy
Eligibility Criteria
Inclusion Criteria:
- A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent
Exclusion Criteria:
- The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.
Sites / Locations
- Donostia Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Early lymphedema detection
Usual follow-up
Arm Description
Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery. Lower Limb measurement and care education
The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
Outcomes
Primary Outcome Measures
Efficacy of the implantation of a standardized postoperative follow-up for the early detection of lymphedema secondary to lymphadenectomy in gynecological cancer
Lower Limb measurement secondary to lymphadenectomy in gynecological cancer
Secondary Outcome Measures
Implementation of educational strategy for patients and professionals
Care education questionnaire results
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03917771
Brief Title
Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer
Official Title
Study to Evaluate the Efficacy of Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer and Implantation of the Protocol
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
August 1, 2018 (Actual)
Study Completion Date
August 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Donostia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aims to detect and treat early lower limb lymphedema secondary to lymphadenectomy with the aim of increasing the quality of life of patients with this chronic condition.
To this end, a group of patients (treatment group) will be referred to the Rehabilitation service for a previous consultation and after surgery where lymphedema could be detected early. In addition, the usual follow-up will be carried out in Gynecology Oncology consultation (GO). In the second group, also called control, will be performed the usual follow-up in GO.
For this we randomize to one of these two groups. The research project has the favorable report of the Center's Clinical Research Ethics Committee
Detailed Description
METHODOLOGY:
Type of study: A) Randomized clinical trial B) Prospective cohort observational study
Study period: from January 2017 to December 2017.
Scope: health area of the province of Gipuzkoa and the University Hospital of Donostia as a reference center.
Selection of the population:
4.1. The inclusion criteria will be: A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent 4.2. The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.
4.3. Sample size: A) Assuming that according to previous studies the overall incidence of lymphedema after LPL is 21% (Hareyama et al), its estimated that a minimum sample of 44 patients will bi needed in order to be able to demonstrate at least 4-fold detection (Torres et al) of Lymphedemas with early follow-up with alpha = 0.05 and beta = 0.2, estimating that habitual follow-up detects 13% of lymphedema ( Mohler III et al).
4.4. Recruitment Process: Will be selected consecutively and offered to participate in the study.
5.1 Intervention: A) After diagnosis and programming for surgery at the GO consultation, circometry is performed by a trained nurse. During the admission, the nurse delivers and explains recommendations sheet and is offered to participate in the clinical trial giving him the Informed Consent (IC) and Information Sheet created for this purpose. In case of accepting and signing the IC, it is randomized (total randomization) according to system of envelopes with code.
Distribution of the intervention;
Treatment group: Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education
Control group: The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
The pelvic lymphadenectomy will be performed by the same surgical team using a transperitoneal approach. The limits of lymph node dissection will be: the psoas muscle, laterally, the postero-medially internal iliac artery, the bifurcation of the common iliac artery cranially, where it crosses the ureter, and caudally the origin of the epigastric vessels, to level of the deep circumflex iliac vein.
B) After diagnosis and programming for surgery at the GO consultation, circometry is performed by trained and yearly nurse. During the entrance, it is delivered and explains the recommendations sheet. SNB is performed by detecting sentinel ganglion from the above mentioned areas according to the protocol of the service. The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lymphedema of Limb, Sentinel Lymph Node
Keywords
physiotherapy
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Recruitment Process: patients will be selected consecutively and offered to participate in the study
Masking
Outcomes Assessor
Masking Description
randomization according to system of envelopes with code
Allocation
Randomized
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Early lymphedema detection
Arm Type
Experimental
Arm Description
Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery. Lower Limb measurement and care education
Arm Title
Usual follow-up
Arm Type
Active Comparator
Arm Description
The usual follow-up will be carried out in GO consultation (0,1,6,12 months)
Intervention Type
Other
Intervention Name(s)
Early lymphedema detection
Intervention Description
Face-to-face consultation in Rehabilitation for early detection of lymphedema after surgery (1,6,12 months). Lower Limb measurement and care education
Intervention Type
Other
Intervention Name(s)
Usual follow-up
Intervention Description
Usual follow-up carried out in GO consultation
Primary Outcome Measure Information:
Title
Efficacy of the implantation of a standardized postoperative follow-up for the early detection of lymphedema secondary to lymphadenectomy in gynecological cancer
Description
Lower Limb measurement secondary to lymphadenectomy in gynecological cancer
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Implementation of educational strategy for patients and professionals
Description
Care education questionnaire results
Time Frame
12 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
A) Diagnostic gynecological cancer patients submitted to bilateral laparoscopic pelvic lymphadenectomy as laparotomics (B: Sentinel Node Biopsy study, SNB) within the usual surgical protocol, with expected survival greater than 12 weeks and adequate liver, renal and medullary functions to accept And sign informed consent
Exclusion Criteria:
The exclusion criteria for the study will be: Blood clotting or hematological disorders, previous thromboembolic disease and history of lymphatic system disease (lymphedema or lymphocele), contraindication for physiotherapy or who do not wish to participate and / or do not sign informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
IBON JAUNARENA
Organizational Affiliation
Hospital Donostia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Donostia Hospital
City
San Sebastián
State/Province
Gipuzkoa
ZIP/Postal Code
20014
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer
We'll reach out to this number within 24 hrs